These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30471415)

  • 21. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats.
    Eakin K; Li Y; Chiang YH; Hoffer BJ; Rosenheim H; Greig NH; Miller JP
    PLoS One; 2013; 8(12):e82016. PubMed ID: 24312624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain Injury.
    Ferguson S; Mouzon B; Paris D; Aponte D; Abdullah L; Stewart W; Mullan M; Crawford F
    J Neurotrauma; 2017 Apr; 34(8):1676-1691. PubMed ID: 27889957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease.
    Athauda D; Foltynie T
    Neuropharmacology; 2018 Jul; 136(Pt B):260-270. PubMed ID: 28927992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
    Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
    Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of the neuroprotective effect of GLP-1 in a rat model of Parkinson's with pre-existing diabetes.
    Elbassuoni EA; Ahmed RF
    Neurochem Int; 2019 Dec; 131():104583. PubMed ID: 31654678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease.
    Yu SJ; Chen S; Yang YY; Glotfelty EJ; Jung J; Kim HK; Choi HI; Choi DS; Hoffer BJ; Greig NH; Wang Y
    Front Neurosci; 2020; 14():785. PubMed ID: 32848559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The investigation of protective effects of glucagon-like peptide-1 (GLP-1) analogue exenatide against glucose and fructose-induced neurotoxicity.
    Khalilnezhad A; Taskiran D
    Int J Neurosci; 2019 May; 129(5):481-491. PubMed ID: 30422728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
    Kim DS; Choi HI; Wang Y; Luo Y; Hoffer BJ; Greig NH
    Cell Transplant; 2017 Sep; 26(9):1560-1571. PubMed ID: 29113464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer's disease.
    An J; Zhou Y; Zhang M; Xie Y; Ke S; Liu L; Pan X; Chen Z
    Behav Brain Res; 2019 Sep; 370():111932. PubMed ID: 31082410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon.
    Li Y; Vaughan KL; Tweedie D; Jung J; Kim HK; Choi HI; Kim DS; Mattison JA; Greig NH
    Sci Rep; 2019 Nov; 9(1):17208. PubMed ID: 31748513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild Hyperthermia Aggravates Glucose Metabolic Consequences in Repetitive Concussion.
    Blaya M; Truettner J; Zhao W; Bramlett H; Dietrich WD
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
    Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
    Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early onset senescence and cognitive impairment in a murine model of repeated mTBI.
    Schwab N; Ju Y; Hazrati LN
    Acta Neuropathol Commun; 2021 May; 9(1):82. PubMed ID: 33964983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memantine Reduced Cell Death, Astrogliosis, and Functional Deficits in an in vitro Model of Repetitive Mild Traumatic Brain Injury.
    Effgen GB; Morrison B
    J Neurotrauma; 2017 Feb; 34(4):934-942. PubMed ID: 27450515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and Persistent Alterations of Cerebellar Inflammatory Networks and Glial Activation in a Rat Model of Pediatric Mild Traumatic Brain Injury.
    Fraunberger EA; DeJesus P; Zanier ER; Shutt TE; Esser MJ
    J Neurotrauma; 2020 Jun; 37(11):1315-1330. PubMed ID: 31808365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.
    Li Y; Chigurupati S; Holloway HW; Mughal M; Tweedie D; Bruestle DA; Mattson MP; Wang Y; Harvey BK; Ray B; Lahiri DK; Greig NH
    PLoS One; 2012; 7(2):e32008. PubMed ID: 22384126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of cognitive deficits after mild traumatic brain injury due to hyperthermia.
    Titus DJ; Furones C; Atkins CM; Dietrich WD
    Exp Neurol; 2015 Jan; 263():254-62. PubMed ID: 25447938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
    Navratilova E; Rau J; Oyarzo J; Tien J; Mackenzie K; Stratton J; Remeniuk B; Schwedt T; Anderson T; Dodick D; Porreca F
    Cephalalgia; 2019 Dec; 39(14):1762-1775. PubMed ID: 31550910
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.